Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Tela Bio Inc's Business Segments
Tela Bio Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Single reportable segment
Total Revenue
$ 19
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Single reportable segment0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single reportable segment | $ 19 | - |
Description of Tela Bio Inc
Tela Bio Inc is a medical technology company specializing in the development and manufacturing of advanced surgical implants. The company focuses on creating products that enhance tissue repair and accelerate healing, ultimately improving patient outcomes.
Tela Bio was founded in 2012 by Antony Koblish, a medical device industry veteran, who recognized the need for innovative solutions in the field of surgical reconstruction. The company's headquarters is located in Malvern, Pennsylvania, and it operates with a team of experienced professionals in various disciplines, including research and development, manufacturing, and commercialization.
The core technology developed by Tela Bio is a unique bioengineered mesh called OviTex. OviTex is constructed using a patented process that combines biologic and synthetic materials, resulting in a hybrid scaffold with optimal properties for tissue reinforcement and regeneration. The mesh is designed to promote the growth of new tissue, providing support and strength while allowing for the integration of native tissue.
Tela Bio's OviTex is used in a wide range of surgical procedures, spanning multiple medical specialties. The bioengineered mesh is particularly suited for use in hernia repair, abdominal wall reconstruction, and soft tissue reinforcement. It is compatible with both open and laparoscopic surgical techniques and has demonstrated superior outcomes compared to traditional mesh products.
One of the key advantages of OviTex is its unique biocompatibility. The mesh is designed to minimize the risk of complications such as infection and adhesion formation, which are common issues associated with other surgical meshes. Additionally, OviTex offers excellent strength and flexibility, allowing it to conform to the patient's anatomy and withstand the demanding biomechanical forces experienced during the healing process.
Tela Bio's commitment to scientific rigor and clinical evidence is evident in its extensive research and development efforts. The company conducts rigorous preclinical testing and collaborates with leading surgeons to design clinical studies that demonstrate the safety and effectiveness of its products. Tela Bio has also established strategic partnerships with renowned academic institutions to advance the understanding of tissue repair and develop innovative solutions.
The company has received several regulatory approvals for its products, including clearance from the U.S. Food and Drug Administration (FDA). It also holds numerous patents related to its technology and has a robust intellectual property portfolio.
In addition to its flagship OviTex product line, Tela Bio offers a comprehensive range of surgical solutions, including fixation devices, biologic implants, and tools to facilitate minimally invasive procedures. These complementary products further enhance the company's ability to provide comprehensive solutions for surgeons and improve patient outcomes.
Overall, Tela Bio Inc is a pioneering medical technology company that is revolutionizing the field of surgical reconstruction. Through its innovative bioengineered mesh technology, the company is setting a new standard for tissue repair and regeneration, helping patients recover faster and with fewer complications. With a commitment to scientific research, clinical evidence, and strategic partnerships, Tela Bio is poised to continue its growth and make a significant impact in the healthcare industry.
Tela Bio was founded in 2012 by Antony Koblish, a medical device industry veteran, who recognized the need for innovative solutions in the field of surgical reconstruction. The company's headquarters is located in Malvern, Pennsylvania, and it operates with a team of experienced professionals in various disciplines, including research and development, manufacturing, and commercialization.
The core technology developed by Tela Bio is a unique bioengineered mesh called OviTex. OviTex is constructed using a patented process that combines biologic and synthetic materials, resulting in a hybrid scaffold with optimal properties for tissue reinforcement and regeneration. The mesh is designed to promote the growth of new tissue, providing support and strength while allowing for the integration of native tissue.
Tela Bio's OviTex is used in a wide range of surgical procedures, spanning multiple medical specialties. The bioengineered mesh is particularly suited for use in hernia repair, abdominal wall reconstruction, and soft tissue reinforcement. It is compatible with both open and laparoscopic surgical techniques and has demonstrated superior outcomes compared to traditional mesh products.
One of the key advantages of OviTex is its unique biocompatibility. The mesh is designed to minimize the risk of complications such as infection and adhesion formation, which are common issues associated with other surgical meshes. Additionally, OviTex offers excellent strength and flexibility, allowing it to conform to the patient's anatomy and withstand the demanding biomechanical forces experienced during the healing process.
Tela Bio's commitment to scientific rigor and clinical evidence is evident in its extensive research and development efforts. The company conducts rigorous preclinical testing and collaborates with leading surgeons to design clinical studies that demonstrate the safety and effectiveness of its products. Tela Bio has also established strategic partnerships with renowned academic institutions to advance the understanding of tissue repair and develop innovative solutions.
The company has received several regulatory approvals for its products, including clearance from the U.S. Food and Drug Administration (FDA). It also holds numerous patents related to its technology and has a robust intellectual property portfolio.
In addition to its flagship OviTex product line, Tela Bio offers a comprehensive range of surgical solutions, including fixation devices, biologic implants, and tools to facilitate minimally invasive procedures. These complementary products further enhance the company's ability to provide comprehensive solutions for surgeons and improve patient outcomes.
Overall, Tela Bio Inc is a pioneering medical technology company that is revolutionizing the field of surgical reconstruction. Through its innovative bioengineered mesh technology, the company is setting a new standard for tissue repair and regeneration, helping patients recover faster and with fewer complications. With a commitment to scientific research, clinical evidence, and strategic partnerships, Tela Bio is poised to continue its growth and make a significant impact in the healthcare industry.
Tela Bio Inc. is a biotechnology company focused on developing and commercializing regenerative medicine products to address challenging surgical needs. Their primary focus is on surgically implantable devices that integrate with the body to enhance healing and support tissue regeneration. Here are the key segments, products, and services offered by Tela Bio Inc.:
Segments
1. Regenerative Medicine: Tela Bio operates primarily within the regenerative medicine space, concentrating on products that facilitate repair and regeneration of human tissues. This segment emphasizes innovative approaches to surgical recovery, enhancing the body’s natural healing processes.
2. Surgical Reconstruction: Another critical segment includes providing solutions for surgical reconstruction, particularly in orthopedic, plastic, and reconstructive surgeries where there is a need for durable, biocompatible materials that can support tissue and organ regeneration.
3. Wound Healing: Tela Bios products also play a role in advanced wound healing solutions, targeting chronic and acute wounds that require specialized scaffolds to promote healing.
Products
1. OviTex:
- OviTex Reinforced Tissue Matrix: This is one of the flagship products of Tela Bio designed for hernia repair and soft tissue reconstruction. It features a unique collagen-based matrix that is reinforced and designed to be fully resorbable, allowing for the regeneration of native tissue while offering structural support during the healing process. OviTex is derived from ovine (sheep) forestomach tissues, providing a suitable scaffold for tissue integration.
2. OviTex PRS:
- OviTex PRS (Plastic and Reconstructive Surgery): A variation of the original OviTex, this product is tailored specifically for plastic and reconstructive surgery procedures. It incorporates advanced features for optimal performance in complex surgical environments, allowing for better integration and long-term outcomes.
3. OviTex Hernia Repair:
- This product extends the use of the OviTex technology to the specific needs of hernia repair surgeries. Equipped with properties that cater to abdominal wall reconstruction, it aims to reduce complications often associated with traditional mesh materials.
4. Surgical Mesh:
- Tela Bio offers a line of surgical meshes that can be utilized in various surgical applications. These meshes are designed to provide excellent tissue integration and support while minimizing the risk of complications such as infection or rejection.
Services
1. Surgical Support and Education:
- Tela Bio often engages in educational initiatives and support services for surgeons and healthcare providers. This includes training sessions, workshops, and webinars aimed at educating surgical teams on best practices for the use of their products, thereby enhancing patient outcomes.
2. Clinical Research Collaborations:
- The company may collaborate with healthcare institutions to conduct clinical research aimed at further validating the efficacy and safety of its products. These partnerships help gather real-world data to support product claims and continuously refine their offerings.
3. Customer Support Services:
- Tela Bio provides comprehensive customer support tailored to healthcare professionals, ensuring they have access to the resources they need for a seamless integration of the companys products into surgical practice.
In summary, Tela Bio Inc. positions itself as a leader in the field of regenerative medicine, with a portfolio that includes innovative products designed for surgical reconstruction, hernia repair, and advanced wound healing. Their commitment to education and customer support further enhances the value of their offerings in the medical field.
Segments
1. Regenerative Medicine: Tela Bio operates primarily within the regenerative medicine space, concentrating on products that facilitate repair and regeneration of human tissues. This segment emphasizes innovative approaches to surgical recovery, enhancing the body’s natural healing processes.
2. Surgical Reconstruction: Another critical segment includes providing solutions for surgical reconstruction, particularly in orthopedic, plastic, and reconstructive surgeries where there is a need for durable, biocompatible materials that can support tissue and organ regeneration.
3. Wound Healing: Tela Bios products also play a role in advanced wound healing solutions, targeting chronic and acute wounds that require specialized scaffolds to promote healing.
Products
1. OviTex:
- OviTex Reinforced Tissue Matrix: This is one of the flagship products of Tela Bio designed for hernia repair and soft tissue reconstruction. It features a unique collagen-based matrix that is reinforced and designed to be fully resorbable, allowing for the regeneration of native tissue while offering structural support during the healing process. OviTex is derived from ovine (sheep) forestomach tissues, providing a suitable scaffold for tissue integration.
2. OviTex PRS:
- OviTex PRS (Plastic and Reconstructive Surgery): A variation of the original OviTex, this product is tailored specifically for plastic and reconstructive surgery procedures. It incorporates advanced features for optimal performance in complex surgical environments, allowing for better integration and long-term outcomes.
3. OviTex Hernia Repair:
- This product extends the use of the OviTex technology to the specific needs of hernia repair surgeries. Equipped with properties that cater to abdominal wall reconstruction, it aims to reduce complications often associated with traditional mesh materials.
4. Surgical Mesh:
- Tela Bio offers a line of surgical meshes that can be utilized in various surgical applications. These meshes are designed to provide excellent tissue integration and support while minimizing the risk of complications such as infection or rejection.
Services
1. Surgical Support and Education:
- Tela Bio often engages in educational initiatives and support services for surgeons and healthcare providers. This includes training sessions, workshops, and webinars aimed at educating surgical teams on best practices for the use of their products, thereby enhancing patient outcomes.
2. Clinical Research Collaborations:
- The company may collaborate with healthcare institutions to conduct clinical research aimed at further validating the efficacy and safety of its products. These partnerships help gather real-world data to support product claims and continuously refine their offerings.
3. Customer Support Services:
- Tela Bio provides comprehensive customer support tailored to healthcare professionals, ensuring they have access to the resources they need for a seamless integration of the companys products into surgical practice.
In summary, Tela Bio Inc. positions itself as a leader in the field of regenerative medicine, with a portfolio that includes innovative products designed for surgical reconstruction, hernia repair, and advanced wound healing. Their commitment to education and customer support further enhances the value of their offerings in the medical field.